11 citations
,
November 2020 in “Movement Disorders Clinical Practice” A man developed neurological issues from SARS-CoV-2 without severe breathing problems, worsening to death.
11 citations
,
January 2019 in “Dermatologic Surgery” Hair follicle transplants help heal wounds, but scar quality and hair growth vary by location.
11 citations
,
May 2013 in “Journal of the American Academy of Dermatology” Hydroxychloroquine helped two people regrow hair lost from alopecia totalis.
11 citations
,
January 2010 in “Journal of oral and maxillofacial surgery”
The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.
6 citations
,
January 2013 in “Chemical & pharmaceutical bulletin/Chemical and pharmaceutical bulletin” A new compound shows promise as a topical treatment for hair loss.
4 citations
,
June 2025 in “Medeniyet Medical Journal” TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.
3 citations
,
February 2023 in “Journal of Infection and Public Health” More symptoms during initial COVID infection increase the risk of long-term effects.
3 citations
,
February 2022 in “Journal of Infection” People with no symptoms or mild COVID-19 have lower antibody levels, increasing their risk of getting COVID-19 again.
3 citations
,
May 2020 in “JAAD Case Reports” Two patients with psoriasis grew extra hair after using certain psoriasis medications.
3 citations
,
July 1988 in “International Journal of Dermatology” Minoxidil is safe and effective for treating early male pattern baldness.
2 citations
,
March 2021 in “Journal of Cosmetic Dermatology” Combining platelet-rich plasma therapy with low dose oral minoxidil improved hair growth in men with hair loss, with slightly higher satisfaction at the higher minoxidil dose.
1 citations
,
June 2023 in “BMC Pediatrics” Most children recovered from COVID-19 in 4 weeks, but some experienced long-term symptoms, especially older kids.
1 citations
,
August 2021 in “Journal of The American Academy of Dermatology” Baricitinib was effective in treating both early and late onset alopecia areata.
1 citations
,
December 2020 in “Media Keperawatan Politeknik Kesehatan Makassar” Nutritional care and education improved blood glucose control and nutrition in a Type 2 Diabetes patient.
1 citations
,
July 2016 in “PubMed” Once-daily 5% minoxidil foam and twice-daily 2% minoxidil solution are similarly effective and safe for female pattern hair loss.
1 citations
,
January 2008 Topical iodine can help regenerate human scar tissue quickly.
1 citations
,
August 2004 in “Alternative & complementary therapies” Non-drug methods like diet, supplements, and aromatherapy can help manage hair loss and its emotional impact.
May 2026 in “JDDG Journal der Deutschen Dermatologischen Gesellschaft” Use topical corticosteroids for alopecia areata, consider systemic treatments like corticosteroids or JAK inhibitors for severe cases, and inform about cosmetic options.
May 2026 in “Frontiers in Medicine” The shampoo effectively reduces scabs after hair transplant surgery without causing discomfort.
February 2026 in “Cureus” Combination therapy is better for long-term control and outcomes in type 2 diabetes.
January 2026 in “Open Science Framework” Biochanin A from soy is a promising and safe candidate for treating hair loss.
January 2026 in “Dermatologic Therapy” 0.5% minoxidil mesotherapy is more effective and safe for hair growth in women with androgenetic alopecia than topical 2% minoxidil.
April 2025 in “Al-Azhar International Medical Journal /Al-Azhar International Medical Journal” Minoxidil is the most common treatment for male hair loss, but sildenafil shows promise as an alternative.
February 2025 in “Universidade Nova de Lisboa's Repository (Universidade Nova de Lisboa)” December 2024 in “Journal of Investigative Dermatology” People with androgenetic alopecia had milder COVID-19 symptoms during the Omicron wave in China.
Essential oils in a nanoemulsion help hair grow better than minoxidil 2% in mice.
September 2023 in “Journal of the American Academy of Dermatology” Guselkumab significantly improves psoriasis symptoms within 12 weeks.
The pandemic worsened mental health and healthcare access for middle-aged women, leading to negative changes in their lifestyle.